Loricrin downregulation and epithelial-related disorders: a systematic review.
Journal
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
ISSN: 1610-0387
Titre abrégé: J Dtsch Dermatol Ges
Pays: Germany
ID NLM: 101164708
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
04
12
2018
accepted:
19
06
2019
pubmed:
18
12
2019
medline:
1
8
2020
entrez:
18
12
2019
Statut:
ppublish
Résumé
Loricrin downregulation has been associated with age-related changes as well as inherited and inflammatory skin diseases. We hypothesize that changes in loricrin could be more related to altered barrier function and consequently disorders that affect epithelial cells, such as psoriasis, atopic dermatitis (AD), erythrokeratoderma, loricrin keratoderma (LK) and periodontitis. The aim of this review is to summarize what is known about the association between loricrin downregulation and epithelial-related disorders (ERDs). A search was performed on the following databases: Medline, Cochrane Library, PubMed, EMBASE, Lilacs, Scopus and Google Scholar, resulting in 16 included articles. Loricrin keratoderma was the ERD most frequently associated with loricrin mutations (730insG, 709insC and 578insG; 5/7 cases - 71.44 %). Atopic dermatitis was the ERD most frequently associated with loricrin downregulation (2/7 cases - 28.6 %). Mutilating palmoplantar keratoderma, progressive symmetrical erythrokeratoderma and a new type of erythrokeratoderma were not associated with any mutations. At the gene level, periodontitis patients showed the highest decrease (-6.89x), followed by AD (-6.5x) and psoriasis patients (-0.5x). In summary, loricrin mutation and downregulation were associated with several ERDs. The diversity in disease presentation is likely related to whether there is a total loss of loricrin, mislocalization and/or if the mutant form of loricrin causes dysfunction of other proteins and/or changes in cornification.
Substances chimiques
Membrane Proteins
0
RNA, Messenger
0
loricrin
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1227-1238Informations de copyright
© 2019 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.
Références
Xu X, Kawachi Y, Nakamura Y et al. Yin-yang 1 negatively regulates the differentiation-specific transcription of mouse loricrin gene in undifferentiated keratinocytes. J Invest Dermatol 2004; 123: 1120-6.
Jackson SM, Williams ML, Feingold KR, Elias PM. Pathobiology of the stratum corneum. West J Med 1993; 158: 279-85.
Schmuth M, Fluhr JW, Crumrine DC et al. Structural and functional consequences of loricrin mutations in human loricrin keratoderma (Vohwinkel syndrome with ichthyosis). J Invest Dermatol 2004; 122: 909-22.
Ishida-Yamamoto A, Iizuka H. Structural organization of cornified cell envelopes and alterations in inherited skin disorders. Exp Dermatol 1998; 7: 1-10.
Steinert PM, Marekov LN. The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isodipeptide cross-linked components of the human epidermal cornified cell envelope. J Biol Chem 1995: 17702-71.
Hohl D, Mehrel T, Lichti U et al. Characterization of human loricrin. structure and function of a new class of epidermal cell envelope proteins. J of Biol Chem 1991; 266: 6626-36.
Steven AC, Steinert PM. Protein composition of cornified cell envelopes of epidermal keratinocytes. J Cell Sci 1994; 107 (Pt 2): 693-700.
Kalinin A, Marekov LN, Steinert PM. Assembly of the epidermal cornified cell envelope. J Cell Sci 2001; 114: 3069-70.
Steinert PM, Kartasova T, Marekov L. Biochemical evidence that small proline-rich proteins and trichohyalin function in epithelia by modulation of the biomechanical properties of their cornified cell envelopes. J Biol Chem 1998; 273: 11758-69.
Candi E, Melino G, Mei G et al. Biochemical, structural, and transglutaminase substrate properties of human loricrin, the major epidermal cornified cell envelope protein. J Biol Chem 1995; 270: 26382-90.
Presland RB, Jurevic RJ. Making sense of the epithelial barrier: what molecular biology and genetics tell us about the functions of oral mucosal and epidermal tissues. J Dent Educ 2002; 66: 564-74.
Kypriotou M, Huber M, Hohl D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the “fused genes” family. Exp Dermatol 2012; 21: 643-9.
Moore JH. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003; 56: 73-82.
Ishida-Yamamoto A, Takahashi H, Iizuka H. Loricrin and human skin diseases: Molecular basis of loricrin keratodermas. Histol Histopathol 1998; 13: 819-26.
Guzeldemir-Akcakanat E, Sunnetci-Akkoyunlu D, Orucguney B et al. Gene-expression profiles in generalized aggressive periodontitis: A gene network-based microarray analysis. J Periodontol 2016; 87: 58-65.
Maestrini E, Monaco AP, McGrath JA et al. A molecular defect in loricrin, the major component of the cornified cell envelope, underlies Vohwinkel’s syndrome. Nat Genet 1996; 13: 70-7.
O’Driscoll J, Muston GC, McGrath JA et al. A recurrent mutation in the loricrin gene underlies the ichthyotic variant of Vohwinkel syndrome. Clin Exp Dermatol 2002; 27: 243-6
Song S, Shen C, Song G et al. A novel c.545-546insG mutation in the loricrin gene correlates with a heterogeneous phenotype of loricrin keratoderma. Br J Dermatol 2008; 159: 714-9.
Takahashi H, Kinouchi M, Tamura T, Iizuka H. Decreased beta 2-adrenergic receptor-mRNA and loricrin-mRNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: Analysis by reverse transcription-polymerase chain reaction. Br J Dermatol 1996; 134: 1065-9.
Ishida-Yamamoto A, McGrath JA, Lam H et al. The molecular pathology of progressive symmetric erythrokeratoderma: A frameshift mutation in the loricrin gene and perturbations in the cornified cell envelope. Am J Hum Genet 1997; 61: 581-9.
Matsumoto K, Muto M, Seki S et al. Loricrin keratoderma: a cause of congenital ichthyosiform erythroderma and collodion baby. Br J Dermatol 2001; 145: 657-60.
Hohl D, Huber M. The ichthyoses. Pathophysiological models of epidermal differentiation. Hautarzt 2013; 64: 12-21.
Armstrong DK, McKenna KE, Hughes AE. A novel insertional mutation in loricrin in Vohwinkel’s keratoderma. J Invest Dermatol 1998; 111: 702-4.
Joanna Briggs Institute [internet]. Adelaide: Checklist for case series; c1996-2018 [cited 2017 Jul 13]. Available from: http://joannabriggs.org/assets/docs/critical-appraisal-tools/JBI_Critical_Appraisal-Checklist_for_Case_Series.pdf [Last accessed August 28, 2019].
Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA group. preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. Open Med 2009; 3: 123-30.
Korge BP, Ishida-Yamamoto A, Punter C et al. Loricrin mutation in Vohwinkel’s keratoderma is unique to the variant with ichthyosis. J Invest Dermatol 1997; 109: 604-10.
Akiyama M, Christiano AM, Yoneda K, Shimizu H. Abnormal cornified cell envelope formation in mutilating palmoplantar keratoderma unrelated to epidermal differentiation complex. J Invest Dermatol 1998; 111: 133-8.
Yeh JM, Yang MH, Chao SC. Collodion baby and loricrin keratoderma: A case report and mutation analysis. Clin Exp Dermatol 2012; 38: 147-50.
Gedicke MM, Traupe H, Fischer B et al. Towards characterization of palmoplantar keratoderma caused by gain-of-function mutation in loricrin: Analysis of a family and review of the literature. Br J Dermatol 2006; 154: 167-71.
Wei S, Zhou Y, Zhang TD et al. Evidence for the absence of mutations at GJB3, GJB4 and LOR in progressive symmetrical erythrokeratodermia. Clin Exp Dermatol 2011; 36: 399-405.
Akman A, Masse M, Mihci E et al. Progressive symmetrical erythrokeratoderma: Report of a Turkish family and evaluation for loricrin and connexin gene mutations. Clin Exp Dermatol 2008; 33: 582-4.
Jarzab J, Filipowska B, Zebracka J et al. Locus 1q21 gene expression changes in atopic dermatitis skin lesions: Deregulation of small proline-rich region 1A. Int Arch Allergy Immunol 2010; 151: 28-37.
Sugiura H, Ebise H, Tazawa T et al. Large-scale DNA microarray analysis of atopic skin lesions shows overexpression of an epidermal differentiation gene cluster in the alternative pathway and lack of protective gene expression in the cornified envelope. Br J Dermatol 2005; 152: 146-9.
Guttman-Yassky E, Suarez-Farinas M, Chiricozzi A et al. Broad defects in epidermal cornification in atopic dermatitis identified through genomic analysis. J Allergy Clin Immunol 2009; 124: 1235-44.
Ishida-Yamamoto A, Senshu T, Takahashi H et al. Decreased deiminated keratin K1 in psoriatic hyperproliferative epidermis. J Invest Dermatol 2000; 114: 701-5.
Giardina E, Capon F, De Rosa MC et al. Characterization of the loricrin (LOR) gene as a positional candidate for the PSORS4 psoriasis susceptibility locus. Ann Hum Genet 2004; 68: 639-45.
van Steensel MA, van Geel M, Steijlen PM. A new type of erythrokeratoderma. Br J Dermatol 2005; 152: 155-8.
Yoneda K, Steinert PM. Overexpression of human loricrin in transgenic mice produces a normal phenotype. Proc Natl Acad Sci USA 1993; 90: 10754-8.
Suga Y, Jarnik M, Attar PS et al. Transgenic mice expressing a mutant form of loricrin reveal the molecular basis of the skin diseases, Vohwinkel syndrome and progressive symmetric erythrokeratoderma. J Cell Biol 2000; 151: 401-12.
Koch PJ, Viragh PA, Scharer E et al. Lessons from loricrin-deficient mice: Compensatory mechanisms maintaining skin barrier function in the absence of a major cornified envelope protein. J Cell Biol 2000; 151: 389-400.
Nemes Z, Steinert PM. Bricks and mortar of the epidermal barrier. Exp Mol Med 1999; 31: 5-19.
van der Velden AW, Thomas AM. The role of the 50 untranslated region of an mRNA in translation regulation during development. Int J Biochem Cell Biol 1999; 31: 87-106.
Sweeney R, Fan Q, Yao MC. Antisense ribosomes: rRNA as a vehicle for antisense RNAs. Proc Natl Acad Sci USA 1996; 93: 8518-23.
Nowak M, Kraemer B, Haupt M et al. Activation of invariant NK T cells in periodontitis lesions. J Immunol 2013; 190: 2282-91.
Argos P, Rossman MG, Grau UM et al. Thermal stability and protein structure. Biochemistry 1979; 18: 5698-703.
Wimley WC, Gawrisch K, Creamer TP, Whiye SH. Direct measurement of salt-bridge solvation energies using a peptide model system: Implications for protein stability. Proc Natl Acad Sci USA 1996; 93: 2985-90.
Wilson J, Hunt T. Molecular Biology of the Cell. 6th ed: Garland Science; 2014.
Proksch E, Brandner JM, Jensen JM. The skin: an indispensable barrier. Exp Dermatol 2008; 17: 1063-72.
Bernerd F, Magnaldo T, Darmon M. Delayed onset of epidermal differentiation in psoriasis. J Invest Dermatol 1992; 98: 902-10.